Elon Musk Breaking Boundaries: The Inspiring Journey of Neuralink’s First Human Patient towards Self-IndependenceOctober 1, 20250 Benchmark has reaffirmed its “Buy” rating and $475 price target on Tesla stock (NASDAQ: TSLA) as the company gears up…
